Frailty and associated outcomes in patients with transthyretin cardiac amyloidosis

被引：0
|
作者：
Fumagalli, C. [1 ]
Ioannou, A. [2 ]
Cappelli, F. [1 ]
Razvi, Y. [2 ]
Porcari, A. [2 ]
Rauf, M. [2 ]
Martinez-Naharro, A. [2 ]
Venneri, L. [2 ]
Whelan, C. [2 ]
Hawkins, P. [2 ]
Marfella, R. [3 ]
Ungar, A. [1 ]
Marchionni, N. [1 ]
Gillmore, J. [2 ]
Fontana, M. [2 ]
机构：
[1] Careggi Univ Hosp AOUC, Florence, Italy
[2] Natl Amyloidosis Ctr, London, England
[3] Univ Campania L Vanvitelli, Naples, Italy
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Right Atrial Pressure is Associated with Worse Outcomes in Older Adult Patients with Transthyretin Derived (ATTR) Cardiac Amyloidosis.
    Russo, C. R.
    Delisle, S.
    Latif, F.
    Maurer, M. S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S198 - S198
  • [32] Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis
    Rosenbaum, Andrew N.
    AbouEzzeddine, Omar F.
    Grogan, Martha
    Dispenzieri, Angela
    Kushwaha, Sudhir
    Clavell, Alfredo
    Daly, Richard C.
    Edwards, Brooks S.
    TRANSPLANTATION, 2018, 102 (11) : 1909 - 1913
  • [33] Prevalence and Prognostic Significance of Frailty Among Patients With Transthyretin Amyloidosis Cardiomyopathy
    Fine, Nowell M.
    McMillan, Jacqueline M.
    CIRCULATION-HEART FAILURE, 2021, 14 (06) : E008105
  • [34] Prevalence of transthyretin cardiac amyloidosis in patients with aortic stenosis
    Sadraldin, Rozana
    Ahmed, Jamal
    Alkaf, Fahmi
    Ahmed, Mohammed K.
    Bin Mousa, Zakaria
    Alqahtani, Saad A.
    Farghaly, Hussein
    Alasiri, Zahra
    Alodhaib, Raneem
    Bin Shigair, Shehana
    Alqarni, Abdullah
    Alamri, Hussein
    Almoghairi, Abdulrahman
    Alahmari, Saeed
    Bakhsh, Abeer
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2024, 14 (06): : 384 - 395
  • [35] The Future for Patients With Transthyretin Cardiac Amyloidosis Is Looking Brighter
    Patel, Jignesh K. K.
    Maurer, Mathew S. S.
    CIRCULATION, 2022, 146 (22) : 1671 - 1673
  • [36] Cardiac transthyretin amyloidosis in patients with conduction system disease
    Pudich, J.
    Seleng, J.
    Syler, J.
    Palickova, N.
    Kapsova, E.
    Drienikova, D.
    Musiolova, K.
    Pudichova, H.
    Plasek, J.
    Vaclavik, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] Outcomes of Cardiac Resynchronization Therapy in Transthyretin Wild-Type Cardiac Amyloidosis
    Sehrawat, Ojasav
    Alcantara, Hannah P.
    Tan, Nicholas Y.
    Chahal, Anwar A.
    Kashou, Anthony H.
    Latif, Omar S.
    Maanja, Maren
    Siontis, Konstantinos
    Miller, Wayne L.
    Noseworthy, Peter A.
    Lin, Grace
    CIRCULATION, 2022, 146
  • [38] Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis
    Donnellan, Eoin
    Wazni, Oussama
    Kanj, Mohamed
    Elshazly, Mohamed B.
    Hussein, Ayman
    Baranowski, Bryan
    Hanna, Mazen
    Patel, Divyang
    Trulock, Kevin
    Martyn, Michael
    Menon, Venu
    Saliba, Walid
    Jaber, Wael A.
    EUROPACE, 2020, 22 (02): : 259 - 264
  • [39] Transthyretin cardiac amyloidosis in patients with severe aortic stenosis
    Falk, Rodney H.
    Dorbala, Sharmila
    EUROPEAN HEART JOURNAL, 2020, 41 (29) : 2768 - 2770
  • [40] Detection and treatment of arrhythmias in patients with transthyretin cardiac amyloidosis
    Simkova, Ivona
    Aiglova, Renata
    Marczibal, Eniko
    Fedorco, Marian
    Taborsky, Milos
    COR ET VASA, 2025, 67 (01) : 43 - 47
12345